ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753664 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753664; 2) Community: the network communities that were significantly associated with the response to NSC 753664; 3) Molecule: the relationships between components within communities and NSC 753664; 4) MDR: the compounds that were significantly associated with the NSC 753664.

NSC Compound Enrichment Correlation
NSC 748903 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a,4a-diol] 0.0209467683758286 0.24248976
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.0209467683758286 -0.13396162
NSC 113452 Null 0.022188614181866 0.17504857
NSC 141545 Suavedol 0.022188614181866 0.54989265
NSC 151982 Null 0.022188614181866 0.39954434
NSC 264077 Phosphonium, (2-bromoethyl)triphenyl-, bromide 0.022188614181866 0.20304353
NSC 266046 Oxaliplatin 0.022188614181866 0.49883961
NSC 275971 Null 0.022188614181866 0.48126324
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.022188614181866 0.31683235
NSC 329277 Null 0.022188614181866 0.18600855
Total:90  Current:42    [First] [Prev] [Next] [Last]